FDAnews
www.fdanews.com/articles/177996-bangladesh-court-axes-drug-production-at-34-sites

Bangladesh Court Axes Drug Production at 34 Sites

August 16, 2016

The Bangladesh High Court has targeted 34 drug firms for ignoring an earlier ban on their products, demanding that they immediately recall their products.

The 20 API makers and 14 pharmaceutical companies responsible for manufacturing antibiotics, hormones and anticancer drugs, were ordered to cease production in June after inspections revealed they were not complying with WHO good manufacturing practices.

Under the original order, 11 firms were required to cease manufacturing 20 days from June 7, in tandem with the cancellation of their manufacturing licenses and recall of all products.

View today's stories